Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Marsha Moses, Ph.D.

Other Positions

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21CA253051 (MOSES, MARSHA A) Aug 17, 2020 - Jul 31, 2022
    Molecular mechanisms of extracellular vesicle-derived modulation of transcytosis at the blood brain barrier
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Roy R, Stephens AJ, Daisy C, Merritt L, Newcomb CW, Yang J, Dagher A, Curatolo A, Sachdev M, McNeish B, Landis R, van Bokhoven A, El-Hayek A, Froehlich J, Pontari MA, Zurakowski D, Lee RS, Moses MA. Association of Longitudinal Changes in Symptoms and Urinary Biomarkers in Patients with Urological Chronic Pelvic Pain Syndrome (UCCPS): A MAPP Research Network Study. J Urol. 2020 Oct 07; 101097JU0000000000001391. PMID: 33026902.
  2. Guo P, Huang J, Moses MA. Cancer Nanomedicines in an Evolving Oncology Landscape. Trends Pharmacol Sci. 2020 Oct; 41(10):730-742. PMID: 32873407.
  3. French SL, Butov KR, Allaeys I, Canas J, Morad G, Davenport P, Laroche A, Trubina NM, Italiano JE, Moses MA, Sola-Visner M, Boilard E, Panteleev MA, Machlus KR. Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation. Blood Adv. 2020 Jul 14; 4(13):3011-3023. PMID: 32614966.
  4. Morad G, Daisy CC, Otu HH, Libermann TA, Dillon ST, Moses MA. Cdc42-Dependent Transfer of mir301 from Breast Cancer-Derived Extracellular Vesicles Regulates the Matrix Modulating Ability of Astrocytes at the Blood-Brain Barrier. Int J Mol Sci. 2020 May 28; 21(11). PMID: 32481745.
  5. Yang J, Zaman MM, Vlasakov I, Roy R, Huang L, Martin CR, Freedman SD, Serhan CN, Moses MA. Adipocytes promote ovarian cancer chemoresistance. Sci Rep. 2019 09 16; 9(1):13316. PMID: 31527632.
  6. Morad G, Carman CV, Hagedorn EJ, Perlin JR, Zon LI, Mustafaoglu N, Park TE, Ingber DE, Daisy CC, Moses MA. Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis. ACS Nano. 2019 12 24; 13(12):13853-13865. PMID: 31479239.
  7. Guo P, Yang J, Huang J, Auguste DT, Moses MA. Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel. Proc Natl Acad Sci U S A. 2019 09 10; 116(37):18295-18303. PMID: 31451668.
  8. Guo P, Huang J, Moses-Gardner A, Smith ER, Moses MA. Quantitative Analysis of Different Cell Entry Routes of Actively Targeted Nanomedicines Using Imaging Flow Cytometry. Cytometry A. 2019 08; 95(8):843-853. PMID: 31294926.
  9. Morad G, Moses MA. Brainwashed by extracellular vesicles: the role of extracellular vesicles in primary and metastatic brain tumour microenvironment. J Extracell Vesicles. 2019; 8(1):1627164. PMID: 31275532.
  10. Roy R, Morad G, Jedinak A, Moses MA. Metalloproteinases and their roles in human cancer. Anat Rec (Hoboken). 2020 06; 303(6):1557-1572. PMID: 31168956.
  11. Guo P, Moses-Gardner A, Huang J, Smith ER, Moses MA. ITGA2 as a potential nanotherapeutic target for glioblastoma. Sci Rep. 2019 04 17; 9(1):6195. PMID: 30996239.
  12. Guo P, Yang J, Liu D, Huang L, Fell G, Huang J, Moses MA, Auguste DT. Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis. Sci Adv. 2019 03; 5(3):eaav5010. PMID: 30906868.
  13. Day AM, McCulloch CE, Hammill AM, Juhász C, Lo WD, Pinto AL, Miles DK, Fisher BJ, Ball KL, Wilfong AA, Levin AV, Thau AJ, Comi AM, Koenig JI, Lawton MT, Marchuk DA, Moses MA, Freedman SF, Pevsner J. Physical and Family History Variables Associated With Neurological and Cognitive Development in Sturge-Weber Syndrome. Pediatr Neurol. 2019 07; 96:30-36. PMID: 30853154.
  14. Woodworth DC, Dagher A, Curatolo A, Sachdev M, Ashe-McNalley C, Naliboff BD, Labus JS, Landis JR, Kutch JJ, Mayer EA, Lee RS, Moses MA, Ellingson BM. Changes in brain white matter structure are associated with urine proteins in urologic chronic pelvic pain syndrome (UCPPS): A MAPP Network study. PLoS One. 2018; 13(12):e0206807. PMID: 30517112.
    Citations:    Fields:    
  15. Jedinak A, Loughlin KR, Moses MA. Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer. Oncotarget. 2018 Aug 21; 9(65):32534-32550. PMID: 30197761.
    Citations:    Fields:    
  16. Gordon LB, Campbell SE, Massaro JM, D'Agostino RB, Kleinman ME, Kieran MW, Moses MA. Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib. Pediatr Res. 2018 05; 83(5):982-992. PMID: 29342131.
    Citations: 1     Fields:    
  17. Guo P, Huang J, Zhao Y, Martin CR, Zare RN, Moses MA. Nanomaterial Preparation by Extrusion through Nanoporous Membranes. Small. 2018 05; 14(18):e1703493. PMID: 29468837.
    Citations:    Fields:    
  18. Huang J, Guo P, Moses MA. A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells. J Vis Exp. 2018 02 16; (132). PMID: 29553530.
    Citations:    Fields:    Translation:HumansCells
  19. Guo P, Liu D, Subramanyam K, Wang B, Yang J, Huang J, Auguste DT, Moses MA. Nanoparticle elasticity directs tumor uptake. Nat Commun. 2018 01 09; 9(1):130. PMID: 29317633.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  20. Roy R, Dagher A, Butterfield C, Moses MA. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling. Mol Cancer Res. 2017 11; 15(11):1608-1622. PMID: 28765266.
    Citations:    Fields:    Translation:HumansAnimalsCells
  21. Lin RZ, Lee CN, Moreno-Luna R, Neumeyer J, Piekarski B, Zhou P, Moses MA, Sachdev M, Pu WT, Emani S, Melero-Martin JM. Host non-inflammatory neutrophils mediate the engraftment of bioengineered vascular networks. Nat Biomed Eng. 2017; 1. PMID: 28868207.
    Citations: 2     
  22. Shimura T, Ebi M, Yamada T, Yamada T, Katano T, Nojiri Y, Iwasaki H, Nomura S, Hayashi N, Mori Y, Kataoka H, Moses MA, Joh T. Urinary kallikrein 10 predicts the incurability of gastric cancer. Oncotarget. 2017 Apr 25; 8(17):29247-29257. PMID: 28418926.
    Citations: 1     Fields:    Translation:Humans
  23. Dagher A, Curatolo A, Sachdev M, Stephens AJ, Mullins C, Landis JR, van Bokhoven A, El-Hayek A, Froehlich JW, Briscoe AC, Roy R, Yang J, Pontari MA, Zurakowski D, Lee RS, Moses MA. Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. BJU Int. 2017 07; 120(1):130-142. PMID: 28263447.
    Citations: 1     Fields:    Translation:Humans
  24. Guo P, Yang J, Bielenberg DR, Dillon D, Zurakowski D, Moses MA, Auguste DT. A quantitative method for screening and identifying molecular targets for nanomedicine. J Control Release. 2017 Oct 10; 263:57-67. PMID: 28341549.
    Citations:    Fields:    Translation:HumansCells
  25. Guo P, Huang J, Moses MA. Characterization of dormant and active human cancer cells by quantitative phase imaging. Cytometry A. 2017 05; 91(5):424-432. PMID: 28314083.
    Citations: 3     Fields:    Translation:HumansCells
  26. Guo P, Yang J, Jia D, Moses MA, Auguste DT. ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer. Theranostics. 2016; 6(1):1-13. PMID: 26722369.
    Citations: 12     Fields:    Translation:HumansCells
  27. Kieran MW, Chi S, Goldman S, Onar-Thomas A, Poussaint TY, Vajapeyam S, Fahey F, Wu S, Turner DC, Stewart CF, Moses M, Packer RJ, Jakacki R, Banerjee A, Boyett JM, Fouladi M, Kun L. A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors. Childs Nerv Syst. 2015 Sep; 31(9):1433-45. PMID: 26188774.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  28. Yang J, Roy R, Jedinak A, Moses MA. Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases. Cancer J. 2015 Jul-Aug; 21(4):327-36. PMID: 26222086.
    Citations: 3     Fields:    Translation:Humans
  29. Hofmann NA, Yang J, Trauger SA, Nakayama H, Huang L, Strunk D, Moses MA, Klagsbrun M, Bischoff J, Graier WF. The GPR 55 agonist, L-a-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis. Br J Pharmacol. 2015 Aug; 172(16):4107-18. PMID: 25989290.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  30. Nakayama H, Huang L, Kelly RP, Oudenaarden CR, Dagher A, Hofmann NA, Moses MA, Bischoff J, Klagsbrun M. Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins. Biochem Biophys Res Commun. 2015 Aug 14; 464(1):126-32. PMID: 26086095.
    Citations: 1     Fields:    Translation:HumansCells
  31. Jedinak A, Curatolo A, Zurakowski D, Dillon S, Bhasin MK, Libermann TA, Roy R, Sachdev M, Loughlin KR, Moses MA. Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer. BMC Cancer. 2015 Apr 11; 15:259. PMID: 25884438.
    Citations: 8     Fields:    Translation:Humans
  32. Shimura T, Dagher A, Sachdev M, Ebi M, Yamada T, Yamada T, Joh T, Moses MA. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer. Cancer Prev Res (Phila). 2015 Mar; 8(3):240-8. PMID: 25591790.
    Citations: 8     Fields:    Translation:Humans
  33. Jia D, Huang L, Bischoff J, Moses MA. The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells. FASEB J. 2015 Apr; 29(4):1371-82. PMID: 25550468.
    Citations: 3     Fields:    Translation:HumansCells
  34. Guo P, Huang J, Wang L, Jia D, Yang J, Dillon DA, Zurakowski D, Mao H, Moses MA, Auguste DT. ICAM-1 as a molecular target for triple negative breast cancer. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14710-5. PMID: 25267626.
    Citations: 25     Fields:    Translation:HumansAnimalsCells
  35. Pelton K, Coticchia CM, Curatolo AS, Schaffner CP, Zurakowski D, Solomon KR, Moses MA. Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo. Am J Pathol. 2014 Jul; 184(7):2099-110. PMID: 24952430.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  36. Foradori MJ, Chen Q, Fernandez CA, Harper J, Li X, Tsang PC, Langer R, Moses MA. Matrilin-1 is an inhibitor of neovascularization. J Biol Chem. 2014 May 16; 289(20):14301-9. PMID: 24692560.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  37. Guo P, You JO, Yang J, Jia D, Moses MA, Auguste DT. Inhibiting metastatic breast cancer cell migration via the synergy of targeted, pH-triggered siRNA delivery and chemokine axis blockade. Mol Pharm. 2014 Mar 03; 11(3):755-65. PMID: 24467226.
    Citations: 13     Fields:    Translation:HumansCells
  38. Sreenivasan AK, Bachur CD, Lanier KE, Curatolo AS, Connors SM, Moses MA, Comi AM. Urine vascular biomarkers in Sturge-Weber syndrome. Vasc Med. 2013 Jun; 18(3):122-8. PMID: 23720035.
    Citations: 2     Fields:    Translation:Humans
  39. Jia D, Hasso SM, Chan J, Filingeri D, D'Amore PA, Rice L, Pampo C, Siemann DW, Zurakowski D, Rodig SJ, Moses MA. Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo. Blood. 2013 Jan 24; 121(4):707-15. PMID: 23212515.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  40. Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, Bhowmick NA, Rubin MA, D'Souza-Schorey C, Freeman MR. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol. 2012 Nov; 181(5):1573-84. PMID: 23022210.
    Citations: 76     Fields:    Translation:HumansAnimalsCells
  41. Yang J, McNeish B, Butterfield C, Moses MA. Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J. 2013 Jan; 27(1):45-50. PMID: 22982376.
    Citations: 25     Fields:    Translation:HumansCells
  42. Guo P, You JO, Yang J, Moses MA, Auguste DT. Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity. Biomaterials. 2012 Nov; 33(32):8104-10. PMID: 22884683.
    Citations: 14     Fields:    Translation:HumansCells
  43. Nikolova A, Ablasser K, Wyler von Ballmoos MC, Poutias D, Kaza E, McGowan FX, Moses MA, Del Nido PJ, Friehs I. Endogenous angiogenesis inhibitors prevent adaptive capillary growth in left ventricular pressure overload hypertrophy. Ann Thorac Surg. 2012 Nov; 94(5):1509-17. PMID: 22795062.
    Citations: 7     Fields:    Translation:Animals
  44. Govindarajan B, Willoughby L, Band H, Curatolo AS, Veledar E, Chen S, Bonner MY, Abel MG, Moses MA, Arbiser JL. Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia. Vasc Cell. 2012 Jul 05; 4(1):11. PMID: 22765013.
    Citations: 7     
  45. Mannelqvist M, Stefansson IM, Wik E, Kusonmano K, Raeder MB, Øyan AM, Kalland KH, Moses MA, Salvesen HB, Akslen LA. Lipocalin 2 expression is associated with aggressive features of endometrial cancer. BMC Cancer. 2012 May 06; 12:169. PMID: 22559235.
    Citations: 14     Fields:    Translation:Humans
  46. Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B, Dvorak H, Langer R. Forty-year journey of angiogenesis translational research. Sci Transl Med. 2011 Dec 21; 3(114):114rv3. PMID: 22190240.
    Citations: 60     Fields:    Translation:Humans
  47. Roy R, Zurakowski D, Pories S, Moss ML, Moses MA. Potential of fluorescent metalloproteinase substrates for cancer detection. Clin Biochem. 2011 Dec; 44(17-18):1434-9. PMID: 22001071.
    Citations: 8     Fields:    Translation:HumansCells
  48. Coticchia CM, Curatolo AS, Zurakowski D, Yang J, Daniels KE, Matulonis UA, Moses MA. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. Gynecol Oncol. 2011 Nov; 123(2):295-300. PMID: 21889192.
    Citations: 12     Fields:    Translation:Humans
  49. Harten IA, Zahr RS, Lemire JM, Machan JT, Moses MA, Doiron RJ, Curatolo AS, Rothman FG, Wight TN, Toole BP, Gordon LB. Age-dependent loss of MMP-3 in Hutchinson-Gilford progeria syndrome. J Gerontol A Biol Sci Med Sci. 2011 Nov; 66(11):1201-7. PMID: 21852285.
    Citations: 2     Fields:    Translation:HumansCells
  50. Horowitz NS, Penson RT, Duda DG, di Tomaso E, Boucher Y, Ancukiewicz M, Cohen KS, Berlin S, Krasner CN, Moses MA, Jain RK. Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma. Clin Ovarian Cancer Other Gynecol Malig. 2011 Jun; 4(1):26-33. PMID: 21833345.
    Citations: 8     
  51. Zhou B, Honor LB, He H, Ma Q, Oh JH, Butterfield C, Lin RZ, Melero-Martin JM, Dolmatova E, Duffy HS, Gise Av, Zhou P, Hu YW, Wang G, Zhang B, Wang L, Hall JL, Moses MA, McGowan FX, Pu WT. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest. 2011 May; 121(5):1894-904. PMID: 21505261.
    Citations: 164     Fields:    Translation:AnimalsCells
  52. Roy R, Rodig S, Bielenberg D, Zurakowski D, Moses MA. ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis. J Biol Chem. 2011 Jun 10; 286(23):20758-68. PMID: 21493715.
    Citations: 23     Fields:    Translation:HumansCells
  53. Zhang B, Tsang PC, Pate JL, Moses MA. A role for cysteine-rich 61 in the angiogenic switch during the estrous cycle in cows: regulation by prostaglandin F2alpha. Biol Reprod. 2011 Aug; 85(2):261-8. PMID: 21490242.
    Citations: 3     Fields:    Translation:AnimalsCells
  54. Roy R, Moses MA. ADAM12 induces estrogen-independence in breast cancer cells. Breast Cancer Res Treat. 2012 Feb; 131(3):731-41. PMID: 21387162.
    Citations: 12     Fields:    Translation:HumansCells
  55. Fernandez CA, Roy R, Lee S, Yang J, Panigrahy D, Van Vliet KJ, Moses MA. The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor. J Biol Chem. 2010 Dec 31; 285(53):41886-95. PMID: 20940305.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  56. Glasgow CG, Steagall WK, Taveira-Dasilva A, Pacheco-Rodriguez G, Cai X, El-Chemaly S, Moses M, Darling T, Moss J. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir Med. 2010 Jul; 104 Suppl 1:S45-58. PMID: 20630348.
    Citations: 12     Fields:    Translation:Humans
  57. Nicksa GA, O'Neil E, Yu DC, Curatolo AS, McNeish BL, Barnewolt CE, Zurakowski D, Buchmiller TL, Moses MA, Rosen S, Fauza DO. Correlation between prenatal urinary matrix metalloproteinase activity and the degree of kidney damage in a large animal model of congenital obstructive uropathy. J Pediatr Surg. 2010 Jun; 45(6):1120-5. PMID: 20620306.
    Citations:    Fields:    Translation:Animals
  58. Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, Eichler AF, Drappatz J, Hochberg FH, Benner T, Louis DN, Cohen KS, Chea H, Exarhopoulos A, Loeffler JS, Moses MA, Ivy P, Sorensen AG, Wen PY, Jain RK. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010 Jun 10; 28(17):2817-23. PMID: 20458050.
    Citations: 168     Fields:    Translation:HumansCTClinical Trials
  59. Dudley AC, Udagawa T, Melero-Martin JM, Shih SC, Curatolo A, Moses MA, Klagsbrun M. Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors. Blood. 2010 Oct 28; 116(17):3367-71. PMID: 20453162.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  60. Becker CM, Louis G, Exarhopoulos A, Mechsner S, Ebert AD, Zurakowski D, Moses MA. Matrix metalloproteinases are elevated in the urine of patients with endometriosis. Fertil Steril. 2010 Nov; 94(6):2343-6. PMID: 20378112.
    Citations: 7     Fields:    Translation:HumansCells
  61. Novak KB, Le HD, Christison-Lagay ER, Nose V, Doiron RJ, Moses MA, Puder M. Effects of metalloproteinase inhibition in a murine model of renal ischemia-reperfusion injury. Pediatr Res. 2010 Mar; 67(3):257-62. PMID: 19915515.
    Citations: 10     Fields:    Translation:Animals
  62. Sales VL, Mettler BA, Engelmayr GC, Aikawa E, Bischoff J, Martin DP, Exarhopoulos A, Moses MA, Schoen FJ, Sacks MS, Mayer JE. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A. 2010 Jan; 16(1):257-67. PMID: 19698056.
    Citations: 19     Fields:    Translation:AnimalsCells
  63. Nicksa GA, Yu DC, Curatolo AS, McNeish BL, Barnewolt CE, Valim C, Buchmiller TL, Moses MA, Fauza DO. Prenatal urinary matrix metalloproteinase profiling as a potential diagnostic tool in fetal obstructive uropathy. J Pediatr Surg. 2010 Jan; 45(1):70-3. PMID: 20105582.
    Citations: 1     Fields:    Translation:Animals
  64. Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009 Nov 01; 27(31):5287-97. PMID: 19738110.
    Citations: 214     Fields:    Translation:Humans
  65. Yang J, Moses MA. Lipocalin 2: a multifaceted modulator of human cancer. . 2009 Aug; 8(15):2347-52. PMID: 19571677.
    Citations: 29     Fields:    Translation:Humans
  66. Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, Shih SC, Nagy JA, Joyce J, Bogyo M, Kalluri R, Dvorak HF. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res. 2009 May 15; 69(10):4537-44. PMID: 19435903.
    Citations: 36     Fields:    Translation:Animals
  67. Lee PS, Tsang SW, Moses MA, Trayes-Gibson Z, Hsiao LL, Jensen R, Squillace R, Kwiatkowski DJ. Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2-deficient lymphangioleiomyomatosis-like cells. Am J Respir Cell Mol Biol. 2010 Feb; 42(2):227-34. PMID: 19395678.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  68. Manfredi MA, Fox VL, Zurakowski D, Kutok JL, Glickman JN, Moses MA. Matrix metalloproteinases in the urine and tissue of patients with juvenile polyps: potential biomarkers for the presence of polyps. J Pediatr Gastroenterol Nutr. 2009 Apr; 48(4):405-11. PMID: 19330927.
    Citations:    Fields:    Translation:Humans
  69. Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A. 2009 Mar 10; 106(10):3913-8. PMID: 19237579.
    Citations: 100     Fields:    Translation:HumansAnimalsCells
  70. Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res. 2008 Oct 15; 14(20):6610-7. PMID: 18927302.
    Citations: 58     Fields:    Translation:HumansCells
  71. Coticchia CM, Yang J, Moses MA. Ovarian cancer biomarkers: current options and future promise. J Natl Compr Canc Netw. 2008 Sep; 6(8):795-802. PMID: 18926090.
    Citations: 16     Fields:    Translation:Humans
  72. Manfredi MA, Zurakowski D, Rufo PA, Walker TR, Fox VL, Moses MA. Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008 Aug; 14(8):1091-6. PMID: 18338781.
    Citations: 19     Fields:    Translation:Humans
  73. Pories SE, Zurakowski D, Roy R, Lamb CC, Raza S, Exarhopoulos A, Scheib RG, Schumer S, Lenahan C, Borges V, Louis GW, Anand A, Isakovich N, Hirshfield-Bartek J, Wewer U, Lotz MM, Moses MA. Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1034-42. PMID: 18483323.
    Citations: 27     Fields:    Translation:Humans
  74. Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res. 2008 Apr 15; 14(8):2378-86. PMID: 18413828.
    Citations: 52     Fields:    Translation:Humans
  75. Klagsbrun M, Moses MA. Obituary: M. Judah Folkman (1933-2008). Nature. 2008 Feb 14; 451(7180):781. PMID: 18273010.
    Citations: 1     Fields:    Translation:Humans
  76. Alwayn IP, Verbesey JE, Kim S, Roy R, Arsenault DA, Greene AK, Novak K, Laforme A, Lee S, Moses MA, Puder M. A critical role for matrix metalloproteinases in liver regeneration. J Surg Res. 2008 Apr; 145(2):192-8. PMID: 18222481.
    Citations: 13     Fields:    Translation:Animals
  77. Rickert D, Franke RP, Lendlein A, Kelch S, Moses MA. Influence of the surface structure of a multiblock copolymer on the cellular behavior of primary cell cultures of the upper aerodigestive tract in vitro. J Biomed Mater Res A. 2007 Nov; 83(2):558-69. PMID: 17580322.
    Citations: 1     Fields:    Translation:AnimalsCells
  78. Harper J, Yan L, Loureiro RM, Wu I, Fang J, D'Amore PA, Moses MA. Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24. Cancer Res. 2007 Sep 15; 67(18):8736-41. PMID: 17875714.
    Citations: 15     Fields:    Translation:HumansCells
  79. Ge G, Fernández CA, Moses MA, Greenspan DS. Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc Natl Acad Sci U S A. 2007 Jun 12; 104(24):10010-5. PMID: 17548836.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
  80. Smith ER, Manfredi M, Scott RM, Black PM, Moses MA. A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery. 2007 Jun; 60(6):E1148-9; discussion E1149. PMID: 17538362.
    Citations: 10     Fields:    Translation:Humans
  81. Rickert D, Franke RP, Fernández CA, Kilroy S, Yan L, Moses MA. Establishment and biochemical characterization of primary cells of the upper aerodigestive tract. Clin Hemorheol Microcirc. 2007; 36(1):47-64. PMID: 17211061.
    Citations: 1     Fields:    Translation:AnimalsCells
  82. Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian BR, Gura KM, Nose V, Zauscher B, Moses M, Puder M. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol. 2006 Dec; 291(6):G1011-9. PMID: 16844679.
    Citations: 11     Fields:    Translation:Animals
  83. Moses MA, Harper J, Folkman J. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med. 2006 Jun 15; 354(24):2621-2. PMID: 16775248.
    Citations: 37     Fields:    Translation:Humans
  84. Fernández CA, Moses MA. Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4. Biochem Biophys Res Commun. 2006 Jun 23; 345(1):523-9. PMID: 16682001.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  85. Vogel AM, Smithers CJ, Kozakewich HP, Zurakowski D, Moses MA, Burrows PE, Fauza DO, Fishman SJ. Extracellular matrix dynamics associated with tissue-engineered intravascular sclerotherapy. J Pediatr Surg. 2006 Apr; 41(4):757-62. PMID: 16567189.
    Citations:    Fields:    Translation:AnimalsCells
  86. Greene AK, Puder M, Roy R, Arsenault D, Kwei S, Moses MA, Orgill DP. Microdeformational wound therapy: effects on angiogenesis and matrix metalloproteinases in chronic wounds of 3 debilitated patients. Ann Plast Surg. 2006 Apr; 56(4):418-22. PMID: 16557076.
    Citations: 27     Fields:    Translation:Humans
  87. Rickert D, Lendlein A, Peters I, Moses MA, Franke RP. Biocompatibility testing of novel multifunctional polymeric biomaterials for tissue engineering applications in head and neck surgery: an overview. Eur Arch Otorhinolaryngol. 2006 Mar; 263(3):215-22. PMID: 16437250.
    Citations: 7     Fields:    Translation:HumansAnimals
  88. Roy R, Zhang B, Moses MA. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res. 2006 Mar 10; 312(5):608-22. PMID: 16442099.
    Citations: 49     Fields:    Translation:HumansAnimals
  89. Harper J, Moses MA. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications. EXS. 2006; (96):223-68. PMID: 16383021.
    Citations: 26     Fields:    Translation:Humans
  90. Friehs I, Margossian RE, Moran AM, Cao-Danh H, Moses MA, del Nido PJ. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis. Basic Res Cardiol. 2006 May; 101(3):204-13. PMID: 16369727.
    Citations: 25     Fields:    Translation:AnimalsCells
  91. Benisty JI, Folkman J, Zurakowski D, Louis G, Rich S, Langleben D, Moses MA. Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension. Chest. 2005 Dec; 128(6 Suppl):572S. PMID: 16373832.
    Citations: 4     Fields:    Translation:Humans
  92. Fernández CA, Yan L, Louis G, Yang J, Kutok JL, Moses MA. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res. 2005 Aug 01; 11(15):5390-5. PMID: 16061852.
    Citations: 83     Fields:    Translation:HumansAnimalsCells
  93. Marler JJ, Fishman SJ, Kilroy SM, Fang J, Upton J, Mulliken JB, Burrows PE, Zurakowski D, Folkman J, Moses MA. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics. 2005 Jul; 116(1):38-45. PMID: 15995028.
    Citations: 16     Fields:    Translation:Humans
  94. Rickert D, Lendlein A, Kelch S, Franke RP, Moses MA. [Cell proliferation and cellular activity of primary cell cultures of the oral cavity after cell seeding on the surface of a degradable, thermoplastic block copolymer]. Biomed Tech (Berl). 2005 Apr; 50(4):92-9. PMID: 15884705.
    Citations:    Fields:    Translation:AnimalsCells
  95. Zhang B, Yan L, Tsang PC, Moses MA. Matrix metalloproteinase-2 (MMP-2) expression and regulation by tumor necrosis factor alpha (TNFalpha) in the bovine corpus luteum. Mol Reprod Dev. 2005 Feb; 70(2):122-32. PMID: 15570615.
    Citations: 2     Fields:    Translation:AnimalsCells
  96. Rickert D, Lendlein A, Kelch S, Moses MA, Franke RP. Expression of MMPs and TIMPs in primary epithelial cell cultures of the upper aerodigestive tract seeded on the surface of a novel polymeric biomaterial. Clin Hemorheol Microcirc. 2005; 32(2):117-28. PMID: 15764820.
    Citations: 1     Fields:    Translation:AnimalsCells
  97. Shukla A, Dunn AR, Moses MA, Van Vliet KJ. Endothelial cells as mechanical transducers: enzymatic activity and network formation under cyclic strain. Mech Chem Biosyst. 2004 Dec; 1(4):279-90. PMID: 16783924.
    Citations: 4     Fields:    Translation:AnimalsCells
  98. Greene AK, Puder M, Roy R, Kilroy S, Louis G, Folkman J, Moses MA. Urinary matrix metalloproteinases and their endogenous inhibitors predict hepatic regeneration after murine partial hepatectomy. Transplantation. 2004 Oct 27; 78(8):1139-44. PMID: 15502710.
    Citations: 2     Fields:    Translation:Animals
  99. Roy R, Wewer UM, Zurakowski D, Pories SE, Moses MA. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem. 2004 Dec 03; 279(49):51323-30. PMID: 15381692.
    Citations: 58     Fields:    Translation:HumansAnimalsCells
  100. Chang LK, Garcia-Cardeña G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32):11658-63. PMID: 15289610.
    Citations: 86     Fields:    Translation:AnimalsCells
  101. Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Ménard C, Camphausen K. Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol. 2004 Feb 01; 22(3):499-506. PMID: 14752073.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  102. Moses MA, Harper J, Fernández CA. A role for antiangiogenic therapy in breast cancer. Curr Oncol Rep. 2004 Jan; 6(1):42-8. PMID: 14664760.
    Citations: 3     Fields:    Translation:HumansAnimals
  103. Munavalli G, Reisenauer A, Moses M, Kilroy S, Arbiser JL. Weight loss-induced calciphylaxis: potential role of matrix metalloproteinases. J Dermatol. 2003 Dec; 30(12):915-9. PMID: 14739520.
    Citations: 3     Fields:    Translation:Humans
  104. Zhang B, Moses MA, Tsang PC. Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum. Reprod Biol Endocrinol. 2003 Nov 07; 1:85. PMID: 14613539.
    Citations: 1     Fields:    Translation:Animals
  105. Moses MA, Brem H, Langer R. Advancing the field of drug delivery: taking aim at cancer. Cancer Cell. 2003 Nov; 4(5):337-41. PMID: 14667500.
    Citations: 34     Fields:    Translation:HumansAnimalsPHPublic Health
  106. Fernández CA, Butterfield C, Jackson G, Moses MA. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor. J Biol Chem. 2003 Oct 17; 278(42):40989-95. PMID: 12900406.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  107. Solan A, Mitchell S, Moses M, Niklason L. Effect of pulse rate on collagen deposition in the tissue-engineered blood vessel. Tissue Eng. 2003 Aug; 9(4):579-86. PMID: 13678437.
    Citations: 15     Fields:    Translation:Animals
  108. Wu I, Moses MA. BNF-1, a novel gene encoding a putative extracellular matrix protein, is overexpressed in tumor tissues. Gene. 2003 Jun 05; 311:105-10. PMID: 12853144.
    Citations: 5     Fields:    Translation:HumansCells
  109. Camphausen K, Moses MA, Ménard C, Sproull M, Beecken WD, Folkman J, O'Reilly MS. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 2003 Apr 15; 63(8):1990-3. PMID: 12702593.
    Citations: 53     Fields:    Translation:AnimalsCells
  110. Govindarajan B, Bai X, Cohen C, Zhong H, Kilroy S, Louis G, Moses M, Arbiser JL. Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling. J Biol Chem. 2003 Mar 14; 278(11):9790-5. PMID: 12514183.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  111. Rickert D, Moses MA, Lendlein A, Kelch S, Franke RP. The importance of angiogenesis in the interaction between polymeric biomaterials and surrounding tissue. Clin Hemorheol Microcirc. 2003; 28(3):175-81. PMID: 12775899.
    Citations: 6     Fields:    Translation:AnimalsCells
  112. Moses MA, O'Reilly MS. Regulation of angiostatin mobilization by tumor-derived matrix metalloproteinase-2. Methods Mol Med. 2003; 74:375-90. PMID: 12415709.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  113. Panigrahy D, Singer S, Shen LQ, Butterfield CE, Freedman DA, Chen EJ, Moses MA, Kilroy S, Duensing S, Fletcher C, Fletcher JA, Hlatky L, Hahnfeldt P, Folkman J, Kaipainen A. PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest. 2002 Oct; 110(7):923-32. PMID: 12370270.
    Citations: 122     Fields:    Translation:HumansAnimals
  114. Zhang B, Yan L, Moses MA, Tsang PC. Bovine membrane-type 1 matrix metalloproteinase: molecular cloning and expression in the corpus luteum. Biol Reprod. 2002 Jul; 67(1):99-106. PMID: 12080004.
    Citations: 3     Fields:    Translation:Animals
  115. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2):715-20. PMID: 11805326.
    Citations: 139     Fields:    Translation:AnimalsCells
  116. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001 Oct 05; 276(40):37258-65. PMID: 11486009.
    Citations: 167     Fields:    Translation:HumansCells
  117. Fang J, Yan L, Shing Y, Moses MA. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res. 2001 Aug 01; 61(15):5731-5. PMID: 11479208.
    Citations: 24     Fields:    Translation:AnimalsCells
  118. Yan L, Moses MA. A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma. Am J Pathol. 2001 Apr; 158(4):1185-90. PMID: 11290534.
    Citations: 1     Fields:    Translation:HumansAnimals
  119. Stock UA, Wiederschain D, Kilroy SM, Shum-Tim D, Khalil PN, Vacanti JP, Mayer JE, Moses MA. Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem. 2001 Mar 26; 81(2):220-8. PMID: 11241662.
    Citations: 13     Fields:    Translation:AnimalsCells
  120. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res. 2001 Mar 01; 61(5):2207-11. PMID: 11280788.
    Citations: 58     Fields:    Translation:Animals
  121. Wu I, Moses MA. Cloning of a cDNA encoding an isoform of human protein phosphatase inhibitor 2 from vascularized breast tumor. DNA Seq. 2001; 11(6):515-8. PMID: 11696978.
    Citations: 2     Fields:    Translation:HumansCells
  122. Stock UA, Sakamoto T, Hatsuoka S, Martin DP, Nagashima M, Moran AM, Moses MA, Khalil PN, Schoen FJ, Vacanti JP, Mayer JE. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J Thorac Cardiovasc Surg. 2000 Dec; 120(6):1158-67; discussion 1168. PMID: 11088041.
    Citations: 4     Fields:    Translation:Animals
  123. LaMontagne KR, Moses MA, Wiederschain D, Mahajan S, Holden J, Ghazizadeh H, Frank DA, Arbiser JL. Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. Am J Pathol. 2000 Dec; 157(6):1937-45. PMID: 11106566.
    Citations: 18     Fields:    Translation:AnimalsCells
  124. Yan L, Moses MA, Huang S, Ingber DE. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J Cell Sci. 2000 Nov; 113 ( Pt 22):3979-87. PMID: 11058085.
    Citations: 15     Fields:    Translation:HumansCells
  125. Wu I, Moses MA. Angiogenic molecules and mechanisms in breast cancer. Curr Oncol Rep. 2000 Nov; 2(6):566-71. PMID: 11122894.
    Citations: 2     Fields:    Translation:Humans
  126. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G, Moses MA. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):3884-9. PMID: 10760260.
    Citations: 90     Fields:    Translation:AnimalsCells
  127. Scrivani SJ, Moses M, Donoff RB, Kaban LB. Taste perception after lingual nerve repair. J Oral Maxillofac Surg. 2000 Jan; 58(1):3-5; discussion 5-6. PMID: 10632158.
    Citations: 2     Fields:    Translation:Humans
  128. Wen W, Moses MA, Wiederschain D, Arbiser JL, Folkman J. The generation of endostatin is mediated by elastase. Cancer Res. 1999 Dec 15; 59(24):6052-6. PMID: 10626789.
    Citations: 52     Fields:    Translation:HumansCells
  129. Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, Stamp A, Taylor G, Moran AM, Landis W, Langer R, Vacanti JP, Mayer JE. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. 1999 Dec; 68(6):2298-304; discussion 2305. PMID: 10617020.
    Citations: 29     Fields:    Translation:AnimalsCellsPHPublic Health
  130. O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, Folkman J, Moses MA. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem. 1999 Oct 08; 274(41):29568-71. PMID: 10506224.
    Citations: 42     Fields:    Translation:AnimalsCells
  131. Gobet R, Bleakley J, Cisek L, Kaefer M, Moses MA, Fernandez CA, Peters CA. Fetal partial urethral obstruction causes renal fibrosis and is associated with proteolytic imbalance. J Urol. 1999 Sep; 162(3 Pt 1):854-60. PMID: 10458395.
    Citations: 2     Fields:    Translation:AnimalsCells
  132. Klagsbrun M, Moses MA. Molecular angiogenesis. Chem Biol. 1999 Aug; 6(8):R217-24. PMID: 10421764.
    Citations: 35     Fields:    Translation:HumansAnimals
  133. Kräling BM, Wiederschain DG, Boehm T, Rehn M, Mulliken JB, Moses MA. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J Cell Sci. 1999 May; 112 ( Pt 10):1599-609. PMID: 10212153.
    Citations: 15     Fields:    Translation:HumansCells
  134. Moses MA, Wiederschain D, Wu I, Fernandez CA, Ghazizadeh V, Lane WS, Flynn E, Sytkowski A, Tao T, Langer R. Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci U S A. 1999 Mar 16; 96(6):2645-50. PMID: 10077564.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  135. Dethlefsen SM, Raab G, Moses MA, Adam RM, Klagsbrun M, Freeman MR. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. J Cell Biochem. 1998 May 01; 69(2):143-53. PMID: 9548562.
    Citations: 33     Fields:    Translation:HumansAnimalsCells
  136. Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res. 1998 Apr 01; 58(7):1395-9. PMID: 9537238.
    Citations: 61     Fields:    Translation:Humans
  137. Wu I, Moses MA. Molecular cloning and expression analysis of the cDNA encoding rat tissue inhibitor of metalloproteinase-4. Matrix Biol. 1998 Jan; 16(6):339-42. PMID: 9503367.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  138. Suzuki M, Raab G, Moses MA, Fernandez CA, Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem. 1997 Dec 12; 272(50):31730-7. PMID: 9395517.
    Citations: 58     Fields:    Translation:AnimalsCells
  139. Peters CA, Freeman MR, Fernandez CA, Shepard J, Wiederschain DG, Moses MA. Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease. Am J Physiol. 1997 Jun; 272(6 Pt 2):R1960-5. PMID: 9227614.
    Citations: 13     Fields:    Translation:AnimalsCells
  140. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR, Folkman J. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A. 1997 Feb 04; 94(3):861-6. PMID: 9023347.
    Citations: 103     Fields:    Translation:AnimalsCells
  141. Moses MA. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells. 1997; 15(3):180-9. PMID: 9170209.
    Citations: 54     Fields:    Translation:HumansCells
  142. Huang SH, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA. Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Eye Res. 1996 May; 62(5):481-90. PMID: 8759516.
    Citations: 4     Fields:    Translation:Animals
  143. Goldberg MJ, Moses MA, Tsang PC. Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpora lutea and their variation during the estrous cycle. J Anim Sci. 1996 Apr; 74(4):849-57. PMID: 8728007.
    Citations: 6     Fields:    Translation:Animals
  144. Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsbrun M, Langer R. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem. 1996 Mar 01; 60(3):379-86. PMID: 8867813.
    Citations: 20     Fields:    Translation:Animals
  145. Wu I, Moses MA. Cloning and expression of the cDNA encoding rat tissue inhibitor of metalloproteinase 3 (TIMP-3). Gene. 1996 Feb 12; 168(2):243-6. PMID: 8654952.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  146. Moses MA, Klagsbrun M, Shing Y. The role of growth factors in vascular cell development and differentiation. Int Rev Cytol. 1995; 161:1-48. PMID: 7558689.
    Citations: 9     Fields:    Translation:HumansAnimals
  147. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994 Oct 21; 79(2):315-28. PMID: 7525077.
    Citations: 541     Fields:    Translation:AnimalsCells
  148. Rosenthal RA, Moses MA, Shintani Y, Megyesi JF, Langer R, Folkman J. Purification and characterization of two collagenase inhibitors from mouse sarcoma 180 conditioned medium. J Cell Biochem. 1994 Sep; 56(1):97-105. PMID: 7806596.
    Citations: 3     Fields:    Translation:AnimalsCells
  149. Braunhut SJ, Moses MA. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J Biol Chem. 1994 May 06; 269(18):13472-9. PMID: 8175780.
    Citations: 18     Fields:    Translation:AnimalsCells
  150. Moses MA, Shing Y. Production of matrix metalloproteinases and a metalloproteinase inhibitor by swarm rat chondrosarcoma. Biochem Biophys Res Commun. 1994 Feb 28; 199(1):418-24. PMID: 8123044.
    Citations: 2     Fields:    Translation:Animals
  151. Sasisekharan R, Moses MA, Nugent MA, Cooney CL, Langer R. Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A. 1994 Feb 15; 91(4):1524-8. PMID: 7509076.
    Citations: 24     Fields:    Translation:AnimalsCells
  152. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Cao Y, Moses M, Lane WS, Sage EH, Folkman J. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol. 1994; 59:471-82. PMID: 7587101.
    Citations: 47     Fields:    Translation:HumansAnimalsCells
  153. Moses MA. A cartilage-derived inhibitor of neovascularization and metalloproteinases. Clin Exp Rheumatol. 1993 Mar-Apr; 11 Suppl 8:S67-9. PMID: 7686834.
    Citations: 4     Fields:    Translation:HumansAnimals
  154. Moses MA, Sudhalter J, Langer R. Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes. J Cell Biol. 1992 Oct; 119(2):475-82. PMID: 1383232.
    Citations: 7     Fields:    Translation:Animals
  155. Moses MA, Langer R. Metalloproteinase inhibition as a mechanism for the inhibition of angiogenesis. EXS. 1992; 61:146-51. PMID: 1377529.
    Citations:    Fields:    Translation:AnimalsCells
  156. Moses MA, Langer R. A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem. 1991 Nov; 47(3):230-5. PMID: 1724245.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  157. Moses MA, Langer R. Inhibitors of angiogenesis. Biotechnology (N Y). 1991 Jul; 9(7):630-4. PMID: 1370057.
    Citations: 18     Fields:    Translation:HumansAnimals
  158. Langer R, Moses M. Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J Cell Biochem. 1991 Apr; 45(4):340-5. PMID: 2045427.
    Citations: 7     Fields:    Translation:HumansAnimals
  159. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science. 1990 Jun 15; 248(4961):1408-10. PMID: 1694043.
    Citations: 65     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Moses's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (673)
Co-Authors (109)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.